Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
By E. Hylek, Alan S. Go, Yuchiao Chang, Nancy G. Jensvold, Lori Henault, J. Selby, D. Singer. New England Journal of Medicine, 2003
1,301 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Internal Medicine
View Paper: https://www.semanticscholar.org/paper/e9595dbfd83e61bbef091120070ffe08298fbcc5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Gerhard Hindricks
- M. Ezekowitz
- Gregory Y. H. Lip
- A. Goette
- Alan S. Go
- Paulus Kirchhof
- Ulrich Schotten
In Internal Medicine
Citations in the corpus
- The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). (2014, background): “Attempts to identify an optimal benefit–risk range for other antithrombotic medications based on clinical outcome events have met with mixed success for warfarin (15), ximelagatran (16), fondaparinux (17), and rivaroxaban (18).”
- ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit (2006, neutral): “0.(170) Despite anticoagulation of more elderly patients with AF, rates of intracerebral hemorrhage are considerably lower than in the past, typically between 0.”
- The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation (2009, background): “5, reflecting outcomes in the ATRIA Study cohort (13, 14).”
- Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? (2003, background): “0).(10,32) Anticoagulation was associated with nearly a doubling in the relative rate of intracranial hemorrhage, but the additional absolute risk of intracranial hemorrhage on anticoagulation was low.”